X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (361) 361
histone deacetylase inhibitors (239) 239
oncology (213) 213
index medicus (196) 196
depsipeptide fr901228 (186) 186
histone deacetylase inhibitor (159) 159
apoptosis (148) 148
depsipeptide (138) 138
depsipeptides - pharmacology (131) 131
animals (121) 121
cancer (119) 119
cell line, tumor (114) 114
fr901228 (106) 106
chromobacterium-violaceum no-968 (99) 99
enzyme inhibitors - pharmacology (96) 96
male (94) 94
apoptosis - drug effects (93) 93
acetylation (87) 87
fk228 (85) 85
suberoylanilide hydroxamic acid (83) 83
antibiotics, antineoplastic - pharmacology (81) 81
expression (81) 81
female (81) 81
romidepsin (74) 74
pharmacology & pharmacy (73) 73
mice (72) 72
depsipeptides (68) 68
histone deacetylase inhibitors - pharmacology (67) 67
histone deacetylases - metabolism (67) 67
depsipeptides - therapeutic use (66) 66
antineoplastic agents - pharmacology (64) 64
histones - metabolism (63) 63
biochemistry & molecular biology (55) 55
hematology (54) 54
histone deacetylase (54) 54
t-cell lymphoma (54) 54
middle aged (52) 52
dose-response relationship, drug (50) 50
antibiotics, antineoplastic - therapeutic use (49) 49
hdac inhibitors (49) 49
tumor cells, cultured (48) 48
aged (47) 47
antineoplastic agents - therapeutic use (47) 47
histone deacetylase inhibitors - therapeutic use (47) 47
neoplasms - drug therapy (47) 47
gene expression (43) 43
hydroxamic acids - pharmacology (43) 43
in-vivo (42) 42
adult (40) 40
cell proliferation - drug effects (40) 40
drug synergism (40) 40
article (39) 39
phase-i (39) 39
peptides, cyclic (38) 38
cell biology (37) 37
research (36) 36
acetylation - drug effects (35) 35
gene-expression (34) 34
phase-ii trial (33) 33
acute myeloid-leukemia (32) 32
blotting, western (32) 32
down-regulation (32) 32
peptides, cyclic - pharmacology (32) 32
care and treatment (31) 31
enzyme inhibitors - therapeutic use (31) 31
in-vitro (31) 31
activation (30) 30
anti-bacterial agents - pharmacology (30) 30
antitumor-activity (30) 30
cells (30) 30
transcription (30) 30
trichostatin-a (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (29) 29
cancer cells (29) 29
cell cycle - drug effects (29) 29
dna methylation (29) 29
health aspects (29) 29
reverse transcriptase polymerase chain reaction (29) 29
up-regulation (29) 29
analysis (28) 28
differentiation (28) 28
vorinostat (28) 28
chromatin (27) 27
chronic lymphocytic-leukemia (27) 27
depsipeptides - administration & dosage (27) 27
depsipeptides - adverse effects (27) 27
depsipeptides - pharmacokinetics (27) 27
rna, messenger - metabolism (27) 27
treatment outcome (27) 27
cell cycle (26) 26
lymphoma, t-cell, cutaneous - drug therapy (26) 26
proteins (26) 26
acute promyelocytic leukemia (25) 25
hdac inhibitor (25) 25
lymphoma (25) 25
cancer-cells (24) 24
trial (24) 24
valproic acid (24) 24
cell survival - drug effects (23) 23
chemotherapy (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chemistry – A European Journal, ISSN 0947-6539, 10/2009, Volume 15, Issue 42, pp. 11174 - 11186
Journal Article
The Journal of Antibiotics, ISSN 0021-8820, 08/2011, Volume 64, Issue 8, pp. 525 - 531
Journal Article
Journal of Immunotherapy, ISSN 1053-8550, 2001, Volume 24, Issue 2, pp. 151 - 161
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2002, Volume 94, Issue 7, pp. 504 - 513
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2002, Volume 8, Issue 3, pp. 718 - 728
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 07/2003, Volume 102, Issue 2, pp. 652 - 658
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2006, Volume 12, Issue 5, pp. 1547 - 1555
The increased expression of markers associated with a differentiated phenotype, such as P-glycoprotein (Pgp), follows treatment with histone deacetylase... 
MDR1 | ATP-dependent transporters and drug resistance | histone deacetylase inhibitor | BREAST-CANCER CELLS | HISTONE DEACETYLASE INHIBITOR | ADVANCED SOLID TUMORS | ONCOLOGY | SUBEROYLANILIDE HYDROXAMIC ACID | PHASE-I TRIAL | SODIUM-BUTYRATE | CHRONIC LYMPHOCYTIC-LEUKEMIA | P-GLYCOPROTEIN EXPRESSION | THYROID-CARCINOMA CELLS | MULTIDRUG-RESISTANCE | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Leukocytes, Mononuclear - metabolism | Paclitaxel - pharmacology | Antibiotics, Antineoplastic - pharmacology | Drug Resistance, Multiple | Colonic Neoplasms - drug therapy | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Didanosine - pharmacology | Neoplastic Cells, Circulating - metabolism | Drug Resistance, Neoplasm | Depsipeptides - pharmacology | Kidney Neoplasms - metabolism | Neoplasm Proteins - metabolism | RNA, Messenger - metabolism | Colonic Neoplasms - metabolism | Kidney - metabolism | Flow Cytometry | ATP-Binding Cassette Transporters - genetics | Hippocalcin - pharmacology | ATP-Binding Cassette Transporters - metabolism | Sezary Syndrome - drug therapy | Multidrug Resistance-Associated Proteins - genetics | Antineoplastic Agents - pharmacology | Acetylation | Tumor Cells, Cultured | Carcinoma, Renal Cell - drug therapy | Neoplasm Proteins - genetics | Antimetabolites - pharmacology | Kidney - drug effects | RNA, Messenger - genetics | Reverse Transcriptase Polymerase Chain Reaction | Carcinoma, Renal Cell - metabolism | Sezary Syndrome - metabolism | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Histones - metabolism | Kidney Neoplasms - drug therapy | Multidrug Resistance-Associated Proteins - metabolism | Doxorubicin - pharmacology
Journal Article
Molecular Therapy, ISSN 1525-0016, 04/2005, Volume 11, Issue 4, pp. 542 - 552
TRAIL (TNF-related apoptosis-inducing ligand) induces apoptosis in various tumor cell types and is under investigation as a cancer therapeutic. The development... 
depsipeptide | lipid rafts | TRAIL | tumor | adenovirus | apoptosis | gene therapy | Adenovirus | Depsipeptide | Tumor | Lipid rafts | Gene therapy | Apoptosis | CARCINOMA-CELLS | MEDICINE, RESEARCH & EXPERIMENTAL | FAS LIGAND | HISTONE DEACETYLASE INHIBITOR | MEDIATED APOPTOSIS | TRANSGENE EXPRESSION | TUMOR NECROSIS FACTOR | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PROSTATE-CANCER CELLS | IN-VIVO | GENETICS & HEREDITY | GENE-THERAPY | RECOMBINANT ADENOVIRUS | Tumor Necrosis Factor-alpha - metabolism | Genetic Therapy | Prostatic Neoplasms - metabolism | Gene Expression - drug effects | Membrane Glycoproteins - metabolism | Membrane Microdomains - metabolism | Humans | Tumor Necrosis Factor-alpha - genetics | Male | Receptors, TNF-Related Apoptosis-Inducing Ligand | Prostatic Neoplasms - therapy | TNF-Related Apoptosis-Inducing Ligand | Adenoviridae - genetics | Depsipeptides - therapeutic use | Tumor Cells, Cultured | Transgenes | Prostatic Neoplasms - drug therapy | Receptors, Tumor Necrosis Factor - metabolism | Membrane Microdomains - chemistry | Receptors, Tumor Necrosis Factor - analysis | Combined Modality Therapy | Enzyme Inhibitors - therapeutic use | Membrane Glycoproteins - genetics | Apoptosis Regulatory Proteins | Antibiotics, Antineoplastic - therapeutic use | Histone Deacetylase Inhibitors | Genetic Vectors
Journal Article